Home > Financial Ratios > SAKAR HEALTHCARE

SAKAR HEALTHCARE
Core EBITDA Margin

    Back to All Ratios
SAKAR HEALTHCARE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SAKAR HEALTHCARE Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 27.9925.0324.9422.8823.87

What is the latest Core EBITDA Margin ratio of SAKAR HEALTHCARE ?

The latest Core EBITDA Margin ratio of SAKAR HEALTHCARE is 27.99 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar202527.99
Mar202425.03
Mar202324.94
Mar202222.88
Mar202123.87

How is Core EBITDA Margin of SAKAR HEALTHCARE Trending?

Years Core EBITDA Margin % Change
Mar2025 27.99
11.83
Mar2024 25.03
0.36
Mar2023 24.94
9.00
Mar2022 22.88
-4.15
Mar2021 23.87 -

Other Financial Ratios of SAKAR HEALTHCARE


Compare Core EBITDA Margin ratio of peers of SAKAR HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAKAR HEALTHCARE ₹1,156.0 Cr -2.4% -0.5% 123.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr -1.7% -4.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,394.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹100,379.0 Cr -1.1% -6.3% -18.3% Stock Analytics


SAKAR HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAKAR HEALTHCARE

-2.4%

-0.5%

123.3%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses